UMIN ID: UMIN000021373
Registered date:07/03/2016
Rituxan injection drug use-results survey in ABO-incompatible liver transplantation recipients
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | ABO-incompatible liver transplantation |
| Date of first enrollment | 2016/02/29 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Adverse drug reaction occurrences Rejection rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | None |
Related Information
| Primary Sponsor | Zenyaku Kogyo, Co., Ltd. |
|---|---|
| Secondary Sponsor | Chugai Pharmaceutical Co., Ltd. |
| Source(s) of Monetary Support | Zenyaku Kogyo, Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Junko Sakamoto |
| Address | 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo 112-8650 Japan 112-8650 |
| Telephone | 03-3946-1136 |
| Junko_Sakamoto@mail.zenyaku.co.jp | |
| Affiliation | Zenyaku Kogyo, Co., Ltd. Post-Marketing-Surveillance Pharmacovigilance & Quality Assurance Department |
| scientific contact | |
| Name | Junko Sakamoto |
| Address | 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo 112-8650 Japan |
| Telephone | 03-3946-1136 |
| Junko_Sakamoto@mail.zenyaku.co.jp | |
| Affiliation | Zenyaku Kogyo, Co., Ltd. Post-Marketing-Surveillance Pharmacovigilance & Quality Assurance Department |